This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.



  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




TOP STORIES

Important trends point to cloudy future for clinical laboratories and pathology groups in the US
Dark Daily
By every measure, the clinical laboratory industry is entering a high-stakes period during the next 24 months. Powerful trends are reducing lab budgets and payers are cutting the prices paid for medical laboratory testing. The question on everyone's mind is "will it get better or worse in the months ahead?"
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Better understanding of DNA's 'dark matter' may lead to useful new clinical pathology lab tests
Dark Daily
Growing knowledge about DNA "dark matter" may soon make it possible for clinical laboratories to develop new assays that reveal clinical information useful in diagnosing and guiding therapeutic decisions. In genetics, "dark matter" describes the noncoding areas of DNA. Recent discoveries indicate that dark matter plays more important roles than previously thought.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE

Sponsored Content


Zebrafish make a splash in FDA research
U.S. Food and Drug Administration
A tiny fish no wider than your thumbnail may someday make a big difference to your health, but not because it's going to show up on your dinner plate. Zebrafish have been making a splash in the world of scientific research for some time. In 2003, the National Institutes of Health ranked the torpedo-shaped fish the third most important experimental organism after rats and mice, and it's quickly gaining ground.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New brain cancer treatment is more effective, less toxic
University of California, San Francisco via Bioscience Technology
A Phase 2 clinical trial testing a new protocol for treating a relatively rare form of brain cancer, primary CNS lymphoma, may change the standard of care for this disease, according to doctors at University of California, San Francisco who led the research. Described in the Journal of Clinical Oncology, the trial involved 44 patients who were given a combination of high-dose chemotherapy with immune therapy, rather than the standard combination of chemotherapy with a technique known as whole-brain radiotherapy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword BRAIN CANCER.


PRODUCT SHOWCASE
  Hu-on-Hu & Ms-on-Ms Ab Detection

Klear Human
(D103) for Clinical or Pharmaceutical screens of Humanized or Hu-Antibody on human tissues and Klear Mouse (D52) for screening mouse models (transgenic or xenografts) using Ms-Antibody on mouse tissues. Both kits give the highest specificity with no background. More…
 


Miniature wireless device provides laboratory-grade blood test
FierceMobileHealthcare
A tiny implantable device developed by Swiss scientists is designed to act as a portable, personal blood testing laboratory to provide immediate analysis of substances that can then be transmitted to a doctor over a cellular phone network. The device, which measures about 14 mm and is implanted just under the skin, is composed of five sensors, a coil for wireless power as well as miniaturized electronics for radio communication, according to an announcement from EPFL. The implant emits radio waves over a safe frequency which then transmits the information via Bluetooth to a mobile phone.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Researchers create next-generation Alzheimer's disease model
NIH/National Institute of Neurological Disorders and Stroke via ScienceDaily
A new genetically engineered lab rat that has the full array of brain changes associated with Alzheimer's disease supports the idea that increases in a molecule called beta-amyloid in the brain causes the disease, according to a study, published in the Journal of Neuroscience. The study was supported by the National Institutes of Health.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  PRODUCT SHOWCASES
RNAscope: Visualize Single-Copy RNA

RNAscope FFPE Assay Kits make detecting single-copy RNA easy. RNAscope works for virtually any gene in any tissue!

• Exquisite sensitivity & specificity
• Optimized for archival FFPE tissue
• Easy 7-hour IHC-like workflow
• Quantifiable and automatable
• New assays in < 3="">
• Guaranteed assay performance
Spring Bioscience - BRAF V600E


Spring Bioscience is leading the research industry by pioneering novel, next generation antibodies that can differentiate mutant and normal protein, enabling pathologists to see relevant mutations within their cellular context. Having already released Exon19 and EGFR L858R for exclusive use by Ventana Medical Systems, Spring Bioscience has launched BRAF V600E.
Click here to find out more.
StatClick™ Specimen Transport Vials

We’ve added a click and removed the leak. Turn the lid until it clicks. Ship with confidence that your samples and your reputation will stay perfectly preserved. To learn more, please visit us at: www.statlab.com/statclick or contact us at 800-442-3573.


IN THE NEWS


Experimental vaccine shows promise for ovarian cancer
HealthDay
A novel but preliminary new treatment for ovarian cancer has apparently produced complete remission for one patient with an advanced form of the disease, researchers are reporting. The promising results of a Phase I clinical trial for the immunotherapy approach also showed that seven other women had no measurable disease at the end of the trial, the researchers added.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Media's role in cell culture success
Genetic Engineering & Biotechnology News
Many cell culture experts will argue that improvements in media and feed have been more responsible than any other factor in raising production titers for therapeutic proteins. While the "nature vs. nurture" argument is far from settled, culture media is at worst the partner of cell-line development in the quest for productivity, safety and efficacy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Analyzing mammalian cell culture using Raman spectroscopy
AZoM
Mammalian cell cultures are complicated processes by which cells are cultured in controlled conditions. In the industrial scenario, mammalian cultures are basic to the manufacture of viral vaccines and other biological products. Chinese hamster ovary cells in the 1980s began revolutionizing mass culture for medicines and continue to remain the workhorse of the industry for therapeutic protein production.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
RNA in situ hybridization assays
QuantiGene® ViewRNA Assays for multiplex in situ hybridization of any gene. Assays enable single-molecule RNA sensitivity with exceptional specificity in FFPE tissue sections. View data.
Milestone
Milestone was founded in 1988 as a company specializing in advanced microwave instrumentation for analytical and organic chemistry labs. MORE


New genetic link found between normal fetal growth and cancer
redOrbit
Two researchers at the National Institutes of Health discovered a new genetic link between the rapid growth of healthy fetuses and the uncontrolled cell division in cancer. The findings shed light on normal development and on the genetic underpinnings of common cancers. The work, conducted using mouse and human tissue, appears in the issue of the Proceedings of the National Academy of Sciences.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Stellaris RNA FISH Probes

Stellaris RNA FISH is a new research technology that enables direct detection, localization and quantification of RNA. The low cost per assay, simple protocol, and the ability to localize mRNA and lncRNA to organelles and cellular structures provides obvious benefits for life science research. Custom and catalogued probes sets available. MORE
 


Alternative radiation for cancer; intestinal human stem cells; turtle genome
Examiner.com
In a recent article, Asian News International reports on promising research about an alternative cancer treatment: boron neutron capture therapy. The lead researcher is M. Frederick Hawthorne, director of the International Institute of Nano and Molecular Medicine of the University of Missouri. The team infused cancerous cells with boron, and then exposed the cells to neutrons, which caused the boron to shatter and lyse the cells. Benign cells were left unharmed.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


AACR: Targeting luminal breast cancer stem cells with trastuzumab blocks metastatic growth in preclinical models
CancerNetwork
Trastuzumab therapy may be useful for the treatment of luminal breast cancer stem cells, preventing them from growing into macrometastases, according to preclinical results presented at the 2013 American Association for Cancer Research Annual Meeting, held April 6–10 in Washington, D.C. Luminal breast cancers are defined classically by their expression of estrogen and progesterone receptors and by their failure to over express the receptor tyrosine kinase HER2.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Gene therapy cures leukaemia in 8 days (New Scientist)
Scientists discover new DNA regions associated with 3 cancers (Los Angeles Times)
'Bedless hospitals' may reshape clinical pathology laboratory testing (Dark Daily)
Lab automation is happening faster than you think (Laboratory Equipment)
Lab equipment made with 3-D printers could cut costs by 97 percent (The Chronicle of Higher Education)

Don't be left behind. Click here to see what else you missed.
 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
April 10, 2013
April 3, 2013
April 3, 2013
March 29, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063